Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (19576)	3/11/1999 7:44:00 AM
From: Rocon	Respond to of 23519

I assume your source is reliable.....this new coverage with a buy rating will have a positive impact on the price. Any idea of the timetable? Regards. Ron

To: VLAD who wrote (19576)	3/11/1999 9:46:00 AM
From: MythMan	Read Replies (1) \| Respond to of 23519

if there was a reiteration today, it had no effect on the stock price so far.

To: VLAD who wrote (19576)	3/11/1999 10:20:00 AM
From: wvalx	Read Replies (2) \| Respond to of 23519

VLAD, is the new coverage the previously undisclosed positive event?

To: VLAD who wrote (19576)	3/11/1999 6:32:00 PM
From: Edderd	Read Replies (1) \| Respond to of 23519

VLAD Received a Vivus brochure directed to Doctors today which is touting the safety of MUSE. NO increased cardiovascular risk associated with intercourse Not contraindicated in patients using nitrates No known drug-drug interactions No dose adjustment required in patients with renal or hepatic dysfunction or in the elderly No dose adjustment because of fed versus fasted state No reported effect on retinal function accompanied by appropriate 888 phone lines for patients and Docs. Cool Ed